End-stage heart failure secondary to low-dose hydroxychloroquine treatment

Eur Heart J. 2021 Jan 7;42(2):207. doi: 10.1093/eurheartj/ehaa595.
No abstract available

MeSH terms

  • COVID-19*
  • Heart Failure* / chemically induced
  • Heart Failure* / drug therapy
  • Humans
  • Hydroxychloroquine / adverse effects

Substances

  • Hydroxychloroquine